"Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns", which provides in-depth analysis of epilepsy market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada.

1. Epilepsy Therapeutics in Major Develope

2. Summary
• "Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs
with Novel Mechanisms of Action Signal a Shift in Treatment Patterns",
which provides in-depth analysis of epilepsy market within the eight major
developed markets of the US, UK, France, Germany, Italy, Spain, Japan and
Canada. The report provides an estimation of the market size for 2012, along
with market forecasts to 2019. It also covers disease epidemiology, treatment
algorithms, treatment patterns, in-depth analysis of the pipeline, and deal
analysis.
The value of the epilepsy market in the major developed markets amounted
to an estimated $3.4 billion in 2012 and is expected to register a Compound
Annual Growth Rate (CAGR) of 3.9% to reach $4.5 billion by 2019. This
modest growth is attributed to the recent approval of drugs with novel
mechanisms of action that are expected to offer more therapeutic options to
prescribers. The US takes major share of 55% of the global epilepsy market

4. Scope
- A brief introduction to epilepsy, including disease pathogenesis, risk
factors, diagnosis and treatment options
- In-depth analysis of major marketed products covering product
performance, product life-cycle and a heat map depicting comparative
analysis of safety and efficacy parameters
- A comprehensive review of the epilepsy pipeline which includes
individual analysis of promising late-stage pipeline drugs that are most
likely to enter the market during the forecast period. The pipeline is
analyzed on the basis of Phase distribution, molecule type and
molecular target
- Additional clinical trial analysis by Phase, trial size, trial duration and
program failure rate for each molecule type and mechanism of action
- Multi-scenario forecasts of the epilepsy market over the 20122019
period in the eight major developed markets

5. Reasons to buy
• Align your product portfolio to markets with high growth potential
• Develop market entry and expansion strategies by identifying the
potential regions and therapeutic segments poised for strong growth
• Devise effective, tailored strategies for each country through the
understanding of key drivers and barriers in the anti-epileptic drugs
market
• Develop key strategic initiatives based upon an understanding of key
focus areas and leading companies
• Accelerate and strengthen your market position by identifying key
companies for mergers, acquisitions and strategic partnerships
• Check Full Report on :
http://www.jsbmarketresearch.com/healthcare-medical/r-Epilepsy-Therap

6. Epilepsy Therapeutics in Major Developed
Markets to 2019

7. Related Market Research Report
• Allergy Drugs Markets in China
• Arthritis Treatment Drugs Markets in China
• Asthma Treatment Drugs Markets in China
• Diabetes Drugs Markets in China
• Pain and Fever Relief Drugs Markets in China
• Cough Drugs Markets in China

8. About JSB Market Research
• Jsbmarketresearch.com is an online repository of an extensive collection of
market research reports available online. This online portal contains high-
quality reports with well-researched and high-quality content on a wide range
of industries. These market research reports help us give a detailed insight into
new opportunities in the industry, prevailing market trends, competitor
analysis and future prospects.
• JSB’s reports are developed by the domain experts and publishers under a
closely observed surveillance of industry specialists. Therefore, the researched
data is well researched, well- organized and matching up to the best standards
in the industry. Also JSB’s database consists of detailed insights of the leading
players in the global market, products and trends.

9. Contact Us
Support & General Inquiries
Mail : support@jsbmarketresearch.com +91 - 998 729 5242
Billing Support
Mail : billing@jsbmarketresearch.com +91 22 412 366 50
Website http://www.jsbmarketresearch.com

10. Contact Us
Support & General Inquiries
Mail : support@jsbmarketresearch.com +91 - 998 729 5242
Billing Support
Mail : billing@jsbmarketresearch.com +91 22 412 366 50
Website http://www.jsbmarketresearch.com